Loading clinical trials...
Loading clinical trials...
A Phase II Study Evaluating the Role of Sentinel Lymph Node Surgery and Axillary Lymph Node Dissection Following Preoperative Chemotherapy in Women With Node Positive Breast Cancer (T1-4, N1-2, M0) at Initial Diagnosis
Conditions
Interventions
systemic chemotherapy
axillary lymph node dissection
+4 more
Locations
324
United States
University of South Alabama Mitchell Cancer Institute
Mobile, Alabama, United States
Providence Cancer Center
Anchorage, Alaska, United States
Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
East Bay Radiation Oncology Center
Castro Valley, California, United States
Valley Medical Oncology Consultants - Castro Valley
Castro Valley, California, United States
Cancer Care Center at John Muir Health - Concord Campus
Concord, California, United States
Start Date
July 1, 2009
Primary Completion Date
November 1, 2012
Completion Date
April 15, 2023
Last Updated
April 27, 2023
NCT07040891
NCT07547774
NCT06257264
NCT07347600
NCT04740697
NCT05491226
Lead Sponsor
Alliance for Clinical Trials in Oncology
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions